Dividends Calendar Earnings Calendar
CHRS

CHRS | Coherus Biosciences Inc

Coherus Biosciences Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Redwood City, California, United States

Trade prices

  • Volume:
  • Market Cap: 606.22M
  • Prev closed:
  • Open: 17.25
  • High: 17.48
  • Low: 16.47
  • 52 week low: 12.21
  • 52 week high: 22.22
  • Dividends:No Dividends

Next ER: May 8, 2023  After Market Closes



Top Stories (CHRS)

    Company Profile

    Coherus BioSciences, Inc. is a leading global biologics platform company focused on delivering high-quality biosimilar therapeutics that may expand patient access to life-changing medicines in regulated markets worldwide. In 2018, the U.S. Food and Drug Administration approved Coherus? biosimilar UDENYCA® (pegfilgrastim-cbqv). Coherus is headquartered in the heart of California?s Silicon Valley and composed of a team of industry veterans with decades of experience pioneering biologics companies.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 3, 2023
    May 8, 2023-0.96 / -0.701632.4M / 45.84M
    March 6, 2023-0.6 / -0.845.35M / 48.41M
    November 8, 2022-0.96 / -0.7445.4M / 57.27M
    August 4, 2022-0.65 / -0.783860.15M / 62.04M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 2, 2023 7.17 7.62
    7.68
    7.13
    1.0M -6.52%
    May 1, 2023 7.67 7.49
    8
    7.39
    1.0M 6.09%
    Apr 28, 2023 7.23 7.2
    7.37
    7.09
    525K -0.14%
    Apr 27, 2023 7.24 7.55
    7.63
    7.21
    606K -3.6%
    Apr 26, 2023 7.51 7.8
    7.9
    7.46
    913K -3.47%
    Apr 25, 2023 7.78 8.01
    8.13
    7.71
    566K -3.47%
    Apr 24, 2023 8.06 8.31
    8.33
    7.99
    517K -2.89%
    Apr 21, 2023 8.3 7.99
    8.31
    7.95
    622K 4.14%
    Apr 20, 2023 7.97 8.05
    8.24
    7.87
    626K -2.21%
    Apr 19, 2023 8.15 8.06
    8.34
    8.02
    552K -0.24%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2010
    • Employees:291

    News

    News for (CHRS)

    This company doesn't provide a dividend.


    Talk about Coherus Biosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 8, 2023 (Same day)

    pypl six tsn swks dk wdc dvn su dish brk.b enr mck 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 86
    HOLD 14
    SELL 0

    Their Official Profiles 

    LinkedIn

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.